Patricia Carr, SVP, Chief Accounting Officer at Jazz Pharmaceuticals plc (JAZZ), sold 4,660 shares at $171.20 ($798K) on 2025-12-05, disclosed to the SEC on 2025-12-09.
Open-market sale of $798k JAZZ by SVP, Chief Accounting Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $171.11 | 160 | $27K | 3.4% |
| 2 | $171.20 | 4,500 | $770K | 96.6% |
| Total | $171.20 avg | 4,660 | $798K | 100% |
| Filing → |
| JAZZ | SELL | 2025-11-20 | $1.9M | — | Filing → |
| JAZZ | SELL | 2025-03-11 | $314K | — | Filing → |
| JAZZ | SELL | 2025-03-03 | $917K | — | Filing → |